These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22629457)
1. CCL18 in a multiplex urine-based assay for the detection of bladder cancer. Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457 [TBL] [Abstract][Full Text] [Related]
2. A multi-analyte assay for the non-invasive detection of bladder cancer. Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection. Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755 [TBL] [Abstract][Full Text] [Related]
4. Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection. Miyake M; Ross S; Lawton A; Chang M; Dai Y; Mengual L; Alcaraz A; Giacoia EG; Goodison S; Rosser CJ BMC Urol; 2013 Sep; 13():42. PubMed ID: 24011266 [TBL] [Abstract][Full Text] [Related]
5. IL-8 as a urinary biomarker for the detection of bladder cancer. Urquidi V; Chang M; Dai Y; Kim J; Wolfson ED; Goodison S; Rosser CJ BMC Urol; 2012 May; 12():12. PubMed ID: 22559832 [TBL] [Abstract][Full Text] [Related]
6. Multiplex protein signature for the detection of bladder cancer in voided urine samples. Rosser CJ; Ross S; Chang M; Dai Y; Mengual L; Zhang G; Kim J; Urquidi V; Alcaraz A; Goodison S J Urol; 2013 Dec; 190(6):2257-62. PubMed ID: 23764080 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer. Urquidi V; Goodison S; Ross S; Chang M; Dai Y; Rosser CJ J Urol; 2012 Dec; 188(6):2377-83. PubMed ID: 23088986 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples. Zhou BF; Wei JH; Chen ZH; Dong P; Lai YR; Fang Y; Jiang HM; Lu J; Zhou FJ; Xie D; Luo JH; Chen W Oncotarget; 2016 Jul; 7(27):41703-41714. PubMed ID: 27203388 [TBL] [Abstract][Full Text] [Related]
9. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker. Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081 [TBL] [Abstract][Full Text] [Related]
10. Urinary BTA: indicator of bladder cancer or of hematuria. Miyake M; Goodison S; Rizwani W; Ross S; Bart Grossman H; Rosser CJ World J Urol; 2012 Dec; 30(6):869-73. PubMed ID: 22932760 [TBL] [Abstract][Full Text] [Related]
11. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort. Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367 [TBL] [Abstract][Full Text] [Related]
12. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma. Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536 [TBL] [Abstract][Full Text] [Related]
13. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria. Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer. Abd El Gawad IA; Moussa HS; Nasr MI; El Gemae EH; Masooud AM; Ibrahim IK; El Hifnawy NM J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Bard Trak test with voided urine cytology in the diagnosis and follow-up of bladder tumors. Chautard D; Daver A; Bocquillon V; Verriele V; Colls P; Bertrand G; Soret JY Eur Urol; 2000 Dec; 38(6):686-90. PubMed ID: 11111185 [TBL] [Abstract][Full Text] [Related]
16. Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer. Thomas L; Leyh H; Marberger M; Bombardieri E; Bassi P; Pagano F; Pansadoro V; Sternberg CN; Boccon-Gibod L; Ravery V; Le Guludec D; Meulemans A; Conort P; Ishak L Clin Chem; 1999 Apr; 45(4):472-7. PubMed ID: 10102906 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer. Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258 [TBL] [Abstract][Full Text] [Related]
18. Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer? Mahnert B; Tauber S; Kriegmair M; Nagel D; Holdenrieder S; Hofmann K; Reiter W; Schmeller N; Stieber P Clin Chem Lab Med; 2003 Jan; 41(1):104-10. PubMed ID: 12636058 [TBL] [Abstract][Full Text] [Related]
19. A multiplex immunoassay for the non-invasive detection of bladder cancer. Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497 [TBL] [Abstract][Full Text] [Related]
20. Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer. Erdmann K; Salomo K; Klimova A; Heberling U; Lohse-Fischer A; Fuehrer R; Thomas C; Roeder I; Froehner M; Wirth MP; Fuessel S Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]